New study checks cancer drug safety in patients with liver issues
NCT ID NCT07036133
First seen Feb 17, 2026 · Last updated May 24, 2026 · Updated 12 times
Summary
This study looks at how the drug pralatrexate is processed by the body in people with advanced solid tumors or blood cancers who also have mild, moderate, or severe liver problems. Researchers will measure drug levels in the blood and track side effects. The goal is to find the right dose for patients with different degrees of liver impairment. About 24 adults will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Gabrail Cancer Center
RECRUITINGCanton, Ohio, 44718, United States
Contact
-
Karmanos Cancer Institute
RECRUITINGDetroit, Michigan, 48201, United States
Contact
-
Northwestern University - Feinberg School of Medicine
RECRUITINGChicago, Illinois, 60611, United States
Contact
-
TOI Clinical Research
WITHDRAWNCerritos, California, 90703, United States
Conditions
Explore the condition pages connected to this study.